News
The South African rand was little changed in early trade on Tuesday before local jobs data, which economists predict could ...
India's tablet market grew 15% in Q1 2025, driven by demand for premium and 5G devices. Samsung led with 34% market share, ...
SiCarrier, a Chinese chip equipment maker with close links to Huawei, has created a stir with the breadth of its planned ...
Some may associate this nifty device with a hefty price tag, but a Sky deal may make the purchase less of a burden. Apple ...
Enrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks; topline data expected in 2H2026Attack dataset continues to accumulate in RAPIDe-3, a pivotal ...
M&S, one of the best known names in British business, stopped taking online orders on April 25, and its share price has ...
The agency did not offer details about the types of crimes or immigration violations the majority of the people were accused ...
SPRINGFIELD, Ill. – Illinois Gov. JB Pritzker has signed a first-in-the-nation executive order to block the federal ...
UltraProlink has launched four new USB hubs and docking stations designed to provide versatile connectivity for smartphones, ...
Booking flights to take off and land on the weekend is costing you. Per Google Flights data, the most cost-effective flights ...
32mon MSN
Burkina Faso’s junta leader Capt. Ibrahim Traore has sparked a social media debate, with some in Africa praising him and ...
COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update
During the first quarter of 2025, the Company announced successful Phase 1 results from the Phase 1 clinical study of its Avenanthramides tablets. That study involved 72 healthy subjects. There were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results